Edimar Alcides Bocchi

Edimar Alcides Bocchi

Auto-generated profile, based on publicly available information

Edimar Alcides Bocchi

Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in JACC
Verified
Journal Article
Closed access
MAMônica Samuel Avila
Mônica Samuel Avila
SASilvia Moreira Ayub-Ferreira
Silvia Moreira Ayub-Ferreira
MWMauro Rogerio de Barros Wanderley
Mauro Rogerio de Barros Wanderley
FCFatima das Dores Cruz
Fatima das Dores Cruz
SBSara Michelly Gonçalves Brandão
Sara Michelly Gonçalves Brandão
EBEdimar Alcides Bocchi
Edimar Alcides Bocchi

1 September 2017 in JACC
Verified
Journal Article
Closed access
EBEdimar Alcides Bocchi
Edimar Alcides Bocchi
RBReinaldo Bulgarelli Bestetti
Reinaldo Bulgarelli Bestetti
MSMaurício Scanavacca
Maurício Scanavacca
ECEdecio Cunha-Neto
Edecio Cunha-Neto
VIVictor Sarli Issa
Victor Sarli Issa

1 June 2001 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
EBEdimar Alcides Bocchi
Edimar Alcides Bocchi
AFAlfredo Fiorelli
Alfredo Fiorelli

16 June 2023 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
JNJose Antonio Marin Neto
Jose Antonio Marin Neto
ARAnis Rassi
Anis Rassi
GOGlaucia Oliveira
Glaucia Oliveira
LCLuís Claudio Lemos Correia
Luís Claudio Lemos Correia
Alberto Novaes Ramos Jr.Alberto Novaes Ramos Jr.
Alberto Novaes Ramos Jr.
JDJoão Carlos Pinto Dias
João Carlos Pinto Dias
Lista de Siglas/Abreviaturas 18 F-FDG – fluordesoxiglicose marcado com flúor-18 123 I-MIBG – meta-iodo-benzil-guanidina marcado com iodo-123 […] Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023 Lista de Siglas/Abreviaturas 18 F-FDG – fluordesoxiglicose marcado com flúor-18 123 I-MIBG – meta-iodo-benzil-guanidina marcado com iodo-123 […] Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023

27 August 2002 in Circulation
Verified
Journal Article
Closed access
PDF file
EBEdimar Alcides Bocchi
Edimar Alcides Bocchi
GGGuilherme Guimarães
Guilherme Guimarães
AMAmilcar Mocelin
Amilcar Mocelin
FBFernando Bacal
Fernando Bacal
GBGiovanni Bellotti
Giovanni Bellotti
JRJosé Franchini Ramires
José Franchini Ramires
Background— Erectile dysfunction (ED) is common in patients with congestive heart failure (CHF). ED reduces quality of life, and it may affect compliance, thereby impairing the success of CHF treatment. Methods and Results— In the first phase (fixed-dose double-blind, randomized, placebo-controlled, two-way crossover study), we studied in 23 men with CHF the effects of 50 mg sildenafil on exercise and neurohormonal activation. Patients underwent a treadmill 6-minute cardiopulmonary walking (6′WT) test followed by a maximal cardiopulmonary exercise test (ET). In the second phase, patients received sildenafil, taken as required for ED. Sildenafil reduced the heart rate (HR) (bpm) before the 6′WT (from 75±15 to 71±14, P =0.02) and ET (from 75±15 to 71±15, P =0.02); the systolic blood pressure (mm Hg) before the 6′WT (from 116±18 to 108±18, P =0.004) and ET (from 116±15 to 108±17, P =0.001); the diastolic blood pressure before the 6′WT (from 69±9 to 63±11, P =0.01) and ET (from 70±8 to 65±10, P =0.004); and the Ve/V co 2 slope during the 6′WT (from 32±7 to 31±6, P =0.04) and ET (from 33±8 to 31±5, P =0.03). Sildenafil attenuated the HR increment during the 6′WT ( P =0.003) and ET ( P =0.000). Sildenafil increased the peak · o 2 from 16.6±3.4 to 17.7±3.4 mL/kg per min ( P =0.025) and the exercise time from 12.3±3.4 to 13.7±3.2 minutes ( P =0.003). Sildenafil improved most scores of International Index of Erectile Function. Conclusions— Sildenafil was tolerated and effective for ED treatment in CHF, and improved the exercise capacity. The reduction of HR during exercise with sildenafil could theoretically decrease the myocardial oxygen consumption during sexual activity.

1 September 2013 in JACC
Verified
Journal Article
Closed access
EBEdimar Alcides Bocchi
Edimar Alcides Bocchi
AAAlexandra Arias
Alexandra Arias
HVHugo Verdejo
Hugo Verdejo
MDMirta Diez
Mirta Diez
EGEfraín Gómez
Efraín Gómez
PCPablo Castro
Pablo Castro